Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors

Blocking interaction of the immune checkpoint receptor PD-1 with its ligand PD-L1 is associated with good clinical outcomes in a broad variety of malignancies. High levels of PD-L1 promote tumor growth by restraining CD8(+) T-cell responses against tumors. Limiting PD-L1 expression and function is t...

Descripción completa

Detalles Bibliográficos
Autores principales: Palsson-McDermott, Eva M., Dyck, Lydia, Zasłona, Zbigniew, Menon, Deepthi, McGettrick, Anne F., Mills, Kingston H. G., O’Neill, Luke A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646285/
https://www.ncbi.nlm.nih.gov/pubmed/29081778
http://dx.doi.org/10.3389/fimmu.2017.01300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646285/
https://www.ncbi.nlm.nih.gov/pubmed/29081778
http://dx.doi.org/10.3389/fimmu.2017.01300

Ejemplares similares